Roles of type II pneumocytes in macrophage (Mf)-mediated host resistance to pulmonary Mycobacterium tuberculosis (MTB) and M. avium complex (MAC) infections were studied. Electron microscopy of the lung sections of mice given intratracheal infection indicated that the organisms invaded both Mfs and type II pneumocytes. When Mono-Mac-6 Mfs (MM6-Mfs) and A-549 type II pneumocytes (A-549 cells) were cocultivated, bacterial growth in MM6-Mfs was reduced by A-549 cell-derived soluble factors, indicating the roles of type II pneumocytes in Mf-mediated host resistance to mycobacteria. MTB-or MAC-infected A-549 cells showed increased mitochondrial RNA expression of cytokines and surfactant proteins (SPs), in the order tumor necrosis factor-a (TNF-a) > granulocyte-Mf colony-stimulating factor (GM-CSF) . Mf chemoattractant protein > interleukin-8 . SP-D. Anti-TNF-a and anti-GM-CSF antibodies attenuated A-549 cell-dependent inhibition of intramacrophage mycobacteria, indicating their crucial roles in A-549 cell-mediated potentiation of Mf antimycobacterial activity.
Mycobacterium tuberculosis (MTB) and M. avium complex (MAC) are important pathogens that cause persistent pulmonary infections in humans. These pathogens also cause disseminated infections in immunocompromised hosts, including patients with AIDS [1] [2] [3] [4] . It is generally accepted that the cells that initially encounter mycobacterial organisms after inhalation of the pathogens into the alveolar space in the lungs are alveolar macrophages (Mfs) and lung epithelial cells [5] . There are several possible mechanisms by which these mycobacterial organisms penetrate the alveolar epithelial barrier, as follows: The organisms may damage the epithelium by direct cytotoxic effects, or they may penetrate and proliferate in alveolar epithelial cells. Alternatively, alveolar Mfs that engulf these organisms may convey them through the alveolar barrier into the bloodstream and lymphatic system, or the pathogenic organisms may penetrate the alveolar epithelium through tight intercellular junctions [6] .
The following is known concerning the roles of alveolar epithelial cells, especially type II alveolar cells, as portals of mycobacterial entry to the lungs. It has been found that MTB and MAC internalize in and vigorously multiply within not only Mfs, but also type II lung epithelial cells [5] , which indicates that alveolar pneumocytes play roles as sites of bacterial entry and growth in lung infections due to mycobacterial pathogens. In this context, it has been reported that intracellular growth of MTB was more vigorous in the A-549 type II lung epithelial cell line (A-549 cells) than in human monocyte-derived Mfs [7] . We also found that MAC organisms invaded and replicated within A-549 cells, that the degree of their invasiveness was in the order of virulence of organisms [8] , and that intracellular multiplication of MTB was much more vigorous in A-549 cells than in human monocytes [9] . These findings strongly suggested the possibility that MTB and MAC gain access to the host lymphatic and circulatory systems, in part, by directly penetrating the alveolar epithelial lining of infected lung and that the "nonprofessional" phagocytes, including type II alveolar pneumocytes, play important roles as sites of infection and multiplication of these organisms.
However, it has not yet been determined whether MTB and MAC actually translocate across the alveolar epithelium in vivo. Moreover, these pathogens have not been shown to attach to and invade alveolar epithelial cells in vivo. We therefore carried out electron microscopic studies to examine whether MTB and MAC organisms penetrate alveolar pneumocytes, especially type II alveolar epithelial cells, in the lungs of mice after intratracheal challenge with such organisms. In addition, we studied the roles of type II alveolar pneumocytes in the innate host resistance to The animal experimentation guidelines of Shimane Medical University were followed in the animal experimentation performed in this study.
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mycobacterial infections due to MTB and MAC in terms of their regulatory effects on the antimicrobial activity of Mfs against mycobacterial pathogens.
Materials and Methods
Organisms and experimental animals. MTB Kurono and MAC N-444 strains isolated from patients with, respectively, tuberculosis or MAC infection were used. MAC N-444 (serovar 8) was identified as M. avium by a DNA-probe test. These organisms were cultured in Middlebrook 7H9 broth. Bacterial suspensions were prepared in PBS that contained 1.0% bovine serum albumin (BSA) and were stored at 2 80 C until use. Eight-week-old female BALB/c mice purchased from Japan Clea Co. were used in the experiments.
Cell line. A-549 cells and the Mono-Mac-6 human monocytic cell line (MM6-Mfs) with characteristics of matured Mfs [10] were used. These cells were subcultured in RPMI 1640 medium that contained 10% fetal bovine serum (FBS). In some cases, 5% FBS-Ham's F-12K medium was used for the subculture of A-549 cells.
Special agents. Special agents used were as follows: DNase-I (GIBCO BRL), oligo dT primers (GIBCO), Superscript II reverse transcriptase (GIBCO), RNase inhibitor (GIBCO), Taq polymerase (Takara Biomedicals), mouse anti-tumor necrosis factor (TNF)-a monoclonal antibody (MAb; R&D Systems), mouse anti-human granulocyte-Mf colony-stimulating factor (GM-CSF) MAb (R&D), and mouse anti-trinitrophenol MAb (Pharmingen).
Mouse infection. Frozen samples of the test organisms were thawed, diluted in saline, and sonicated (Handy Sonic sonicator; Tomy Seiko) at the maximum power for 2 s. A 100-mL aliquot of the resultant bacterial suspension (5 £ 10 8 cfu/mL) was used for intratracheal challenge of mice that had been anesthetized with pentobarbital.
Transmission electron microscopy (TEM). At intervals after infection, mice were anesthetized with pentobarbital and lungs were perfused with~30 mL of PBS, followed by subsequent perfusion with~20 mL of the fixative solution, which consisted of 2% paraformaldehyde, 2.5% glutaraldehyde, and 0.1 M phosphate buffer (pH 7.3). Whole lungs were then excised and immersed in the fixative solution for 6 h. Tissue was further dissected, postfixed in 1% osmium tetroxided, dehydrated in a graded ethanol series, embedded in epoxy resin in flat molds, and polymerized at 60 C. For ultrastructural studies, thin sections were stained with uranyl acid and lead citrate prior to examination on a transmission electron microscope (model EM-002B; Topcon) at 80 kV. Type II alveolar cells were differentiated from lung Mfs on the basis of their peculiar cell location near the angles between neighboring alveolar septa, the presence of lamellar bodies in the cytoplasm and surface microvilli in the alveolus, and attachment to type I alveolar cells and capillary endothelial cells through basal laminae, as described by Fawcett [11] .
Intracellular bacterial growth. A monolayer culture of A-549 cells was prepared by seeding 5 £ 10 5 cultured cells in a 22-mm culture well (bottom chamber). The resultant A-549 cells were infected with MTB or MAC at MOIs of 10 and 100, respectively, for 2 h, followed by thorough washing with Hanks' balanced salt solution (HBSS) that contained 2% FBS, to remove extracellular organisms. MM6-Mfs (2:5 £ 10 5 cells) were seeded into a 12-mm well equipped with a 0.4-mm Millipore filter-bottom (top chamber; Corning) and then were infected with the microorganisms as mentioned above. Because MM6-Mfs were nonadherent to plastic wells, infected cells were washed with 2% FBS-HBSS by centrifugation (150 g, 5 min) to remove extracellular organisms. Then the top chamber, with or without MM6-Mfs in 0.5 mL of 1% FBS-RPMI 1640 medium, was immersed into the bottom chamber, with or without A-549 cells in 1.5 mL of the culture medium, and was cultivated at 37 C in a CO 2 incubator (5% CO 2 -95% humidified air) for 5 days. At intervals, MM6-Mfs in the top chamber were scraped off by pipetting and were transferred to a tube (16 £ 94 mm). The top chamber was washed with 0.5 mL of culture medium by pipetting, the wash was added to the tube that contained recovered MM6-Mfs, and this procedure was repeated once more. After the washing procedure, we observed, by microscopy, no MM6-Mfs remaining on the bottom of the top chamber. The recovered MM6-Mfs were then lysed with 0.07% SDS, followed by neutralization with 6% BSA-PBS. The colony-forming units of recovered organisms were counted on Middlebrook 7H11 agar plates. In the case of A-549 cells, which tightly adhered to the bottom chamber, the cells were lysed by direct addition of SDS at the final concentration of 0.07%, and the bacterial colony-forming units released from the infected cells were counted, as mentioned above. C for 1 min; annealing at 58 C, 62 C, or 64 C for 2 min; and extension at 72 C for 2 min for each cycle. PCR products were analyzed by electrophoresis on 2% ethidium bromide-stained agarose gels.
Quantitative RT-PCR was performed, using methods described elsewhere [12] , to strictly normalize the amounts of cDNAs for individual cytokines and SPs to the amount of b-actin cDNA in each specimen. In brief, we performed parallel PCRs for test proteins along with PCRs for b-actin on serial 2-fold dilutions of cDNA from each A-549 cell culture, to determine the highest titer of cDNA that yielded a positive PCR for each message. Numerical values for mRNA levels of test proteins in each cell culture were derived from the ratio of the last dilution that gave a positive PCR for each test protein divided by the last dilution that gave a positive PCR for bactin. The obtained values of the ratio for test protein messages in A-549 cells cultured for prescribed intervals (4 and 48 h) were further multiplied by the reciprocal of the ratio for the corresponding test protein messages in A-549 cells at time 0, to fix the time 0 value of the ratio for each test protein as 1. This gave the relative intensity of mRNA expression of test proteins by A-549 cells cultured for various intervals after stimulation due to infection with MTB or MAC.
Statistical analysis. Statistical analysis was performed by Student's t test. P , :05 was considered to be significant.
Results
Internalization of MTB and MAC in type II alveolar cells after intratracheal infection. First, TEM studies were carried out to elucidate profiles of the localization of MTB and MAC within type II alveolar cells in vivo by use of mouse experimental MTB and MAC infection models. Figures 1 and 2 show electron micrographs of type II pneumocytes in the alveoli of mice 2 days after intratracheal infection with MTB or MAC, respectively. In both cases, a few MTB and MAC organisms were observed within cytoplasm of type II alveolar cells (figures 1 and 2, arrows ). All the internalized organisms were in isolated phagosomes. The MTB organisms were in tight contact with the phagosome membrane (figure 1B, arrow ), whereas most of the MAC organisms were in somewhat loose contact with the phagosome membrane and were surrounded by an electron-transparent zone (figure 2B, arrows ), which has been observed elsewhere for certain types of mycobacteria, including M. avium, M. leprae, and M. aurum, and is assumed to be a layer of bacterial glycopeptidolipids called mycosides [13] [14] [15] . Approximately 10% of the organisms observed in pulmonary sections were within type II alveolar epithelial cells, and the remainder had been phagocytosed by alveolar Mfs, interstitial Mfs, or neutrophils in the alveoli and the alveolar walls (micrographs not shown). In TEM fields that were positive for mycobacteria,~10% and 30% of type II pneumocytes had engulfed MTB or MAC, respectively.
As shown in figure 3, at 14 days postinfection, numerous bacteria were present in the early granulomas at sites of infection. In such lesions, the alveoli and alveolar walls included many infiltrating inflammatory cells, including lymphocytes and activated intraepithelial/interstitial Mfs. In this case, many mycobacterial organisms were found within Mf lineages, especially epithelioid cells with numerous lysosomal vesicles. In contrast, few organisms were seen in type II alveolar cells.
Modulatory effects of type II pneumocytes on the mode of intracellular growth of MTB and MAC within Mfs. We next examined the effects of type II alveolar epithelial cells in modulating the intracellular growth of MTB and MAC organisms residing within Mfs. As shown in figure 4A , the growth of MTB of humoral mediators responsible for A-549 cell-mediated upregulation of antimycobacterial activity of MM6-Mfs, A-549 cells with or without mycobacterial infection were examined for mRNA expression of various proinflammatory cytokines (IFNg, TNF-a, and GM-CSF) known to up-regulate Mf antimycobacterial activity [16] [17] [18] . The A-549 cells were also examined for mRNA expression of chemokines (MCP-1 and IL-8) and 2 SPs (SP-A and SP-D) known to be secreted from type II pneumocytes [19, 20] or reported to up-regulate Mf antimicrobial function [21] [22] [23] [24] [25] . Figure 5 shows the expression of mRNAs of proinflammatory cytokines (TNF-a, GM-CSF, MCP-1, and IL-8) and SP-D by A-549 cells infected with MTB or MAC. First, although no or very weak expression of TNF-a and GM-CSF mRNAs was observed in uninfected cells, expression of these mRNAs was significantly increased at 4 h after infection. Although increased expression of TNF-a mRNA continued until 48 h, the GM-CSF mRNA level thereafter decreased to a normal level at 48 h. Notably, MAC infection caused a much more marked increase in the mRNA expression of these cytokines than did MTB infection. Second, MCP-1, IL-8, and SP-D mRNAs were constitutively expressed in uninfected A-549 cells. Although the expression of MCP-1 and IL-8 was increased from 4 to 48 h after MAC infection and was slightly increased 4 h after MTB infection, such an increase was not observed in SP-D mRNA expression. Third, neither IFN-g nor SP-A mRNA was expressed, not even after MTB or MAC infection. Notably, SP-A mRNA expression was not observed, even when RT-PCR was performed that used 2 other sets of the primers specific for SP-A (sense/ antisense): CAGGGACGGGAGAGATGGTG/GCTGGGACC-CTCAGTCAGGC and CCTGGAGAGCGTGGAGAGAA/TCA-GTCGGGAGTACAGGCAG.
We next examined profiles of expression of the above proteins by MTB-or MAC-infected A-549 cells by semiquantitative RT-PCR. As shown in figure 6 , the mRNA expression of TNF-a, GM-CSF, and MCP-1 was increased at 4 h after MTB and MAC infection, especially in the latter case. IL-8 mRNA expression was also increased by MAC infection, whereas MTB infection did not cause such an increase. The same experiment was also performed for the mRNA expression of these cytokines, using quantitative RT-PCR, at 48 h after infection. In addition, SP-D mRNA expression was measured. As shown in table 1, mRNA levels of TNF-a and GM-CSF increased from 4 to 48 h after MTB or MAC infection, whereas increase in the level of MCP-1 mRNA was transiently observed only at 4 h after infection. The increase in IL-8 mRNA expression was more marked in the later phase (48 h) after MTB infection than in the early phase (4 h). MAC infection caused prolonged increase in IL-8 mRNA levels from 4 to 48 h. Changes in SP-D mRNA levels were not observed from 4 to 48 h after MTB or MAC infection. These profiles were essentially the same as those obtained by the ordinary RT-PCR method employed in the experiments shown in figure 5 .
The roles of GM-CSF and TNF-a in A-549 cell-mediated growth inhibition of intramacrophage mycobacteria. The above results strongly suggest that TNF-a and GM-CSF both play important roles as humoral mediators in A-549 cell-mediated upregulation of Mf antimicrobial functions against MTB and MAC (figure 4). To verify this concept, we performed experiments with the blocking anti-TNF-a and anti-GM-CSF Abs, as follows. Using the same dual-chamber system described in figure  4 , MTB-or MAC-infected MM6-Mfs (top chamber) were cocultivated with A-549 cells (bottom chamber) that were either infected or not infected with the corresponding organisms. In that cultivated with uninfected A-549 cells, and Dcfu(anti-TNF-a Ab) was as follows: for MTB, (0:37^0:22Þ £ 10 4 , and for MAC, (0:04^0:04Þ £ 10 6 . Because the former values were significantly larger than the corresponding latter values (P , :01), it is thought that the inhibitory action of MTB-or MAC-infected A-549 cell-derived humoral mediators against intramacrophage bacterial growth was attenuated by anti-TNF-a Ab. Second, anti-GM-CSF Ab markedly increased the growth of MTB and MAC in MM6-Mfs that were cocultivated with infected A-549 cells, and Dcfu(anti-GM-CSF Ab) was ð7:400 :19Þ £ 10 4 for MTB and (1:85^0:19Þ £ 10 6 for MAC. Anti-GM-CSF Abs also potently increased the growth of MTB and MAC in MM6-Mfs when they were cocultivated with uninfected A-549 cells, and Dcfu(anti-GM-CSF Ab) was ð4:120 :46Þ £ 10 4 for MTB and ð1:33^0:06Þ £ 10 6 for MAC. However, the former values were significantly higher than the latter values (P , :01 or , .05), indicating that the anti-GM-CSF Ab significantly attenuated the inhibitory action of MTB-or MAC-infected A-549 cell-derived humoral mediators against the bacterial growth in MM6-Mfs.
Discussion
The present TEM study indicated that both MTB and MAC organisms entered not only phagocytes, such as alveolar Mfs and interstitial Mfs in the alveoli and M cells in the bronchi [26] , but also type II alveolar epithelial cells in the lungs when mice were subjected to mycobacterial challenge via the intratracheal route. This is, to our knowledge, the first observation of mycobacterial internalization within type II pneumocytes in vivo. It thus appears that type II alveolar cells play important roles as a portal of mycobacterial entry to the lung. Bermudez and Goodman [5] reported that the virulent MTB strain H37Rv grew more rapidly than the avirulent H37Ra strain in A-549 cells and proposed that alveolar epithelial cells serve as a reservoir for MTB in the lungs. Similar findings were also observed for growth rates of MAC strains with different levels of virulence in A-549 cells [8] . However, in pulmonary sections of mice at 14 days after infection with MTB or MAC, few mycobacteria were found within type II pneumocytes, although numerous organisms were readily seen within epithelioid cells in the granulomas induced by mycobacterial infection. It thus appears to be likely that type II alveolar cells function as a locus of initial entry into and temporary growth of mycobacteria in the lungs but not as a site for persistent bacterial growth or as a reservoir. The transient nature of the roles played by type II pneumocytes in the formation and progression of lesions of mycobacterial infection is supported by a study by Kanai et al. [27] , who found NOTE. The mRNA expression of test proteins was measured by quantitative reverse-transcription polymerase chain reaction, as in figure 6 . Shown are representative results of 3 independent experiments. Other details are the same as in figure 6 . GM-CSF, granulocyte-macrophage colony-stimulating factor; IL, interleukin; MCP, monocyte chemoattractant protein; SP, surfactant protein; TNF-a, tumor necrosis factor-a. morphological changes in type II pneumocytes in the lungs of M. bovis-infected mice prior to the development of interstitial granulomas. It is thus likely that both MTB and MAC access the subepithelial space, in part, through transcytosis by alveolar epithelial cells, including type II pneumocytes, and are delivered to lymphoid tissue or the circulatory system.
A-549 type II pneumocytes appear to secrete soluble factors that up-regulate the antimycobacterial activity of MM6-Mfs. In the RT-PCR study of profiles of mRNA expression of proinflammatory cytokines and SPs by A-549 cells, TNF-a and GM-CSF mRNA expression was markedly increased early after MTB or MAC infection. Because both TNF-a and GM-CSF are potent activators of cellular functions of Mfs, particularly Mf antimicrobial activity against MTB and MAC [6, [28] [29] [30] , it appears that these cytokines are responsible for the A-549 cellmediated up-regulation of Mf antimycobacterial activity. This concept is strongly supported by the findings shown in figure  7 , which indicate that both anti-TNF-a Ab and anti-GM-CSF Ab attenuated the inhibitory action of MTB-or MAC-infected A-549 cell-derived mediators against intramacrophage growth of the organisms. Notably, the attenuating effect of anti-GM-CSF Ab was much stronger than that of anti-TNF-a Ab, thereby suggesting that GM-CSF and TNF-a, particularly the former, play central roles in the A-549 cell-mediated potentiation of Mf antimycobacterial functions.
Of note, MAC-infected A-549 cells displayed greater increase in mRNA expression of TNF-a and GM-CSF than did MTBinfected A-549 cells, although the growth rate of MTB within A-549 cells was much greater than that of MAC organisms. This may be explained as follows. First, it has been reported that both vitronectin receptor (CD51) and b1 integrin (CD29) play crucial roles as cellular receptors for MTB uptake by A-549 cells [5] . On the other hand, our blocking experiments, which used anti-CD51 and anti-CD29 antibodies, indicated rather minor roles for these receptors in the entry of MAC organisms into A-549 cells (unpublished observations). Second, it has also been reported that MAC uses both trigger and zipper mechanisms to invade human respiratory epithelial cells [31] . These interactions are mediated by 2 bacterial proteins, with molecular weights of 31 and 25 kDa, and MTB also expresses similar proteins. It is also known that exclusive internalization of bacteria by the triggering mechanism is initiated after bacterial binding to specific receptors on the cell surface and subsequent activation of intracellular signal transduction pathways, causing reorganization of the actin cytoskeleton [32] . Third, specific binding of a cellular receptor with its ligand induces the activation of the signal transduction pathways peculiar to individual receptors. Therefore, certain differences in the nature of cellular receptors for MTB and MAC binding may account for the differential modes of TNF-a and GM-CSF mRNA expression by MTB-and MACinfected A-549 cells.
Next, mRNA expression of MCP-1 and IL-8 was also weakly or moderately increased in MTB-or MAC-infected A-549 cells, although these mRNAs were constitutively expressed in uninfected A-549 cells. A study elsewhere by Lin et al. [19] , which used an ELISA system, revealed that MTB, but not MAC, elicited MCP-1 and IL-8 production. We also obtained similar findings in regard to the effects of MTB and MAC on the expression of these chemokines by A-549 cells, as follows (authors' unpublished observations): Although MTB-infected A-549 cells produced increased amounts of MCP-1 (DMCP1 ¼ 134^5 pg/ mL) and IL-8 (DIL-8 ¼ 136^22 pg/mL) during a 2-day cultivation, such an increase was not noted for MAC-infected cells. However, uninfected A-549 cells constitutively produced significant amounts of MCP-1 (563^7 pg/mL) and IL-8 (668^25 pg/mL). Thus, MTB caused only mild up-regulation of the synthesis of these chemokines by A-549 cells. Although MCP-1 and IL-8 lack the ability to potentiate Mf antimycobacterial activity [17] , these chemokines, which are produced by the type II alveolar cells, may play important roles in innate host resistance by eliciting migration and accumulation of phagocyte cells, including Mfs and neutrophils [33, 34] , and may also facilitate the expression of acquired immunity against mycobacteria by attracting CD4 þ T cells [33] . Alveolar epithelial cells are reported to secrete SP-A and SP-D, which are known to up-regulate Mf phagocytic ability and antimicrobial activity [19] [20] [21] [22] [23] . It thus appears that these SPs may contribute to expression of innate host resistance to antimicrobial infections by potentiating Mf antimicrobial functions. In the present study, A-549 cells displayed constitutive expression of SP-D mRNA. Notably, the expression of SP-D mRNA by A-549 cells was not up-regulated by MTB or MAC infection. The A-549 cell-mediated up-regulation of Mf antimycobacterial activity (figure 4) was not attributable to SP-D, because such Mf-activating humoral factors were produced only by A-549 cells infected with MTB or MAC. Although no significant expression of SP-A mRNA was observed in A-549 cells either before or after the entry of these mycobacteria (authors' unpublished observations), this may be due to the peculiar characteristics of this pneumocytic cell line. To elucidate the roles of type II pneumocytes in the formation of MTB and MAC lesions in the lungs, studies (using immunoelectron and confocal microscopy) of the in vivo expression of proinflammatory cytokines (TNF-a and GM-CSF), chemokines (MCP-1 and IL-8), and SPs (SP-A and SP-D) in pulmonary sections of infected mice are currently under way.
